Zacks Investment Research
03 Aug 2026, 15:40 UTC · 1h ago
Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
03 Aug 2026, 15:40 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Quest Diagnostics raised its 2026 revenue guidance to a range of $11.95 billion to $12.05 billion and adjusted earnings guidance to $11.05 to $11.25 per share. — Upwardly revised full-year guidance for both top and bottom lines typically triggers immediate positive price action.
+0.60Quest Diagnostics' second-quarter revenues rose 10.2% to $3.04 billion, exceeding consensus estimates by 2.1%. — An earnings beat demonstrates current operational strength and supports the validity of the raised forward guidance.
+0.40Organic requisition volume grew 13%, though revenue per requisition declined by 2.8%. — Strong volume growth is positive, but the decline in pricing power suggests a slight headwind to margins.
+0.20Continue reading
6 related stories
Top 3 movers · tap to explore
The Corewell Health joint venture is expected to contribute approximately $250 million to 2026 revenues. — While contributing to growth, the text notes that such acquisitions and partnerships may come with lower margins.
+0.10Which stocks this story touches
Raised 2026 revenue and earnings guidance after second-quarter results topped expectations.
Mentioned as a competitor facing a peer (DGX) that is currently seeing strong growth and expanding market share.
Mentioned as operating in the kidney-care ecosystem that Quest Diagnostics is now targeting for growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
1h ago
